Research and Development

The Research and Development team at Pyxis Oncology focuses on the innovative design and rigorous evaluation of biologic therapies, including antibody-drug conjugates and monoclonal antibodies. This interdisciplinary team, comprising experts in bioanalysis, clinical strategy, and manufacturing, works collaboratively to advance the company's pipeline of novel cancer treatments through preclinical studies and clinical trials, ensuring safety, efficacy, and scalability for patients in need.